3,803
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis

, , , , , , , , , & show all
Pages 824-833 | Received 05 Oct 2019, Accepted 01 Apr 2020, Published online: 27 May 2020

References

  • Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010;10(11):803–808.
  • Cheng X, Wei L, Huang X, et al. Solute carrier family 39 member 6 gene promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis. Gastroenterology. 2017;152(8):1985–1997.e1912.
  • Matulonis UA, Sood AK, Fallowfield L, et al. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.
  • Costello LC, Franklin RB. Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. Expert Opin Ther Targets. 2017;21(1):51–66.
  • Clavijo Jordan MV, Lo ST, Chen S, et al. Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate. Proc Natl Acad Sci USA. 2016;113(37):E5464–5471.
  • Li M, Zhang Y, Liu Z, et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci USA. 2007;104(47):18636–18641.
  • Gal D, Lischinsky S, Friedman M, et al. Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA 125 and copper-to-zinc ratio. Gynecol Oncol. 1989;35(2):246–250.
  • Ressnerova A, Raudenska M, Holubova M, et al. Zinc and copper homeostasis in head and neck cancer: review and meta-analysis. Curr Med Chem. 2016;23(13):1304–1330.
  • Fong LY, Jiang Y, Farber JL. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice. Carcinogenesis. 2006;27(7):1489–1496.
  • Liaw KY, Lee PH, Wu FC, et al. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol. 1997;92(12):2260–2263.
  • Uzzo RG, Crispen PL, Golovine K, et al. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006;27(10):1980–1990.
  • Tao M, Xu K, He S, et al. Zinc-ion-mediated self-assembly of forky peptides for prostate cancer-specific drug delivery. Chem Commun (Camb). 2018;54(37):4673–4676.
  • Bailey P, Arrowsmith C, Darling K, et al. A double-blind randomized vehicle-controlled clinical trial investigating the effect of ZnPTO dose on the scalp vs. antidandruff efficacy and antimycotic activity. Int J Cosmet Sci. 2003;25(4):183–188.
  • Mo J, Lin D, Wang J, et al. Apoptosis in HepG2 cells induced by zinc pyrithione via mitochondrial dysfunction pathway: involvement of zinc accumulation and oxidative stress. Ecotoxicol Environ Saf. 2018;161:515–525.
  • Mills KJ, Hu P, Henry J, et al. Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione. Br J Dermatol. 2012;166 Suppl 2(Suppl 2):33–40.
  • Ding WQ, Lind SE. Metal ionophores – an emerging class of anticancer drugs. IUBMB Life. 2009;61(11):1013–1018.
  • Yu H, Zhou Y, Lind SE, et al. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009;417(1):133–139.
  • Poole K. At the nexus of antibiotics and metals: the impact of Cu and Zn on antibiotic activity and resistance. Trends Microbiol. 2017;25(10):820–832.
  • Yu H, Lou JR, Ding WQ. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells. Anticancer Res. 2010;30(6):2087–2092.
  • Lu S, Ke Y, Wu C, et al. Radiosensitization of clioquinol and zinc in human cancer cell lines. BMC Cancer. 2018;18(1):448.
  • Ke Y, Li Y, Zeng Y, et al. Radiosensitization of clioquinol combined with zinc in the nasopharyngeal cancer stem-like cells by inhibiting autophagy in vitro and in vivo. Int J Radiat Oncol Biol Phys. 2018;102(3):e160.
  • Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008; 27(50):6434–6451.
  • Holmes D. Ovarian cancer: beyond resistance. Nature. 2015;527(7579):S217.
  • The L. UKCTOCS and the evaluation of screening for ovarian cancer. Lancet. 2016;387(10022):918.
  • Fukada T, Yamasaki S, Nishida K, et al. Zinc homeostasis and signaling in health and diseases: Zinc signaling. J Biol Inorg Chem. 2011;16(7):1123–1134.
  • Kolenko V, Teper E, Kutikov A, et al. Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol. 2013;10(4):219–226.
  • McQuitty JT, Jr., DeWys WD, Monaco L, et al. Inhibition of tumor growth by dietary zinc deficiency. Cancer Res. 1970;30(5):1387–1390.
  • Jiang WG, Sanders AJ, Katoh M, et al. Tissue invasion and metastasis: molecular, biological and clinical perspectives. Semin Cancer Biol. 2015;35 Suppl:S244–s275.
  • Lightman A, Brandes JM, Binur N, et al. Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy. Clin Chem. 1986;32(1 Pt 1):101–103.
  • Alam S, Kelleher SL. Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutrients. 2012;4(8):875–903.
  • Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2011;41(2):271–290.
  • Ishii K, Otsuka T, Iguchi K, et al. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett. 2004;207(1):79–87.
  • Xin Q, Zhang H, Liu Q, et al. Extracellular biocoordinated zinc nanofibers inhibit malignant characteristics of cancer cell. Nano Lett. 2015;15(10):6490–6493.
  • Winerdal ME, Krantz D, Hartana CA, et al. Urinary bladder cancer tregs suppress MMP2 and potentially regulate invasiveness. Cancer Immunol Res. 2018;6(5):528–538.
  • Yang D, Sun Y, Hu L, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23(2):186–199.
  • Pommier Y, Sordet O, Antony S, et al. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene. 2004;23(16):2934–2949.
  • Kartal-Yandim M, Adan-Gokbulut A, Baran Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol. 2016;36(4):716–726.
  • Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11(10):700–714.
  • Boya P, Andreau K, Poncet D, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med. 2003;197(10):1323–1334.
  • Zhou X, Li Y, Li C. Autophagy plays a positive role in zinc-induced apoptosis in intestinal porcine epithelial cells. Toxicol in Vitro. 2017;44:392–402.
  • Kocdor H, Ates H, Aydin S, et al. Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer. Drug Des Devel Ther. 2015;9:3899–3909.
  • Eron SJ, MacPherson DJ, Dagbay KB, et al. Multiple mechanisms of zinc-mediated inhibition for the apoptotic caspases-3, -6, -7, and -8. ACS Chem Biol. 2018;13(5):1279–1290.
  • Zhang X, Guan T, Yang B, et al. A novel role for zinc transporter 8 in the facilitation of zinc accumulation and regulation of testosterone synthesis in Leydig cells of human and mouse testicles. Metab Clin Exp. 2018;88:40–50.
  • Ning P, Jiang J, Li L, et al. A mitochondria-targeted ratiometric two-photon fluorescent probe for biological zinc ions detection. Biosens Bioelectron. 2016;77:921–927.
  • Wiggins HL, Wymant JM, Solfa F, et al. Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells. Biochem Pharmacol. 2015;93(3):332–342.
  • Abuarab N, Munsey TS, Jiang LH, et al. High glucose-induced ROS activates TRPM2 to trigger lysosomal membrane permeabilization and Zn-mediated mitochondrial fission. Sci Signal. 2017;10(490):eaal4161.
  • Arriaga JM, Greco A, Mordoh J, et al. Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. Mol Cancer Ther. 2014;13(5):1369–1381.
  • Wu N, Zhang C, Wang C, et al. Zinc-doped copper oxide nanocomposites reverse temozolomide resistance in glioblastoma by inhibiting AKT and ERK1/2. Nanomedicine (Lond)). 2018;13(11):1303–1318.